Share
Stem cell therapy Market: Segmented: By Type (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Embryonic Stem Cells and Others); By Technology (Cell Acquisition, Cell Production and Cryopreservation); By Application (Musculoskeletal Disorders, Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases and Others), And Region - Global Analysis of Market Size, Share & Trends For 2019-2020 And Forecasts To 2031
Stem cell therapy Market to surpass USD 27.94 billion by 2031 from USD 11.43 billion in 2021 at a CAGR of 13.4% in the coming years, i.e., 2021-31.
Stem cells, which can proliferate and develop into almost any cell type in the body, are used in surgery and medicine. The stem cell is the source of all cells in the human body. It can replicate itself as well as heal and replace damaged tissues in the human body. Stem cell therapy is a relatively simple procedure that avoids the risks associated with invasive surgical procedures. Furthermore, stem cell therapy uses cells derived from the patient's own body, lowering the risk of immunological rejection. Stem cell therapy is also referred to as regenerative medicine or focal point therapy. Stem cell therapies are also used to treat a variety of chronic illnesses, such as cancer and blood disorders.
The global Stem cell therapy market is expected to project a notable CAGR of 13.4% in 2031.
Rising stem cell research activities and increasing approvals of GMP-certified facilities to manufacture stem cells are driving the market growth. The growing demand for iPSCs as an alternative to ESCs, as well as the growing demand for cell and gene therapies, are expected to drive market growth in the coming years.
Adipose Tissue-Derived Mesenchymal Stem Cells segment to grow with the highest CAGR during 2021-31
Based on type, the global Stem cell therapy Market is fragmented into Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Embryonic Stem Cells, and Others. Because of their growing use in treating inflammatory illnesses, wounds, and traumas, adipose tissue-derived mesenchymal stem cells are expected to dominate the global market during the forecasted period. Furthermore, the numerous benefits of using adipose tissue-derived stem cells, such as the ease of harvesting stem cells using minimally invasive techniques, the simplicity of the isolation approach, and the higher quality and proliferation capacity of the stem cells, will drive the segment even further.
Cell Acquisition segment to grow with the highest CAGR during 2021-31
The global Stem cell therapy market is classified based on category into Cell Acquisition, Cell Production, and Cryopreservation. Cell acquisition held the largest CAGR over the forecast period due to rising research studies involving cell harvesting.
Musculoskeletal Disorders segment to grow with the highest CAGR during 2021-31
Based on application, the global Stem cell therapy Market is fragmented into Musculoskeletal Disorders, Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Others. Because of the rising incidence of musculoskeletal disorders such as osteoarthritis, bone repair, and regeneration, the musculoskeletal disorders segment is expected to dominate the global market during the forecasted period. Furthermore, several governments are heavily investing in the development of regenerative medicines. The medications created will aid in the treatment of a variety of heart diseases, blood disorders, vision loss, and diabetes.
Increasing use in oncology and regenerative medicine
The use of stem cells in regenerative medicine, particularly in dermatology, is expected to drive significant growth in the global Stem Cell Therapy Market during the forecasted period. Furthermore, rising oncology use, as a result of a large number of pipeline medicines in development for the treatment of tumors or malignancies, would propel the market forward. Furthermore, the rising prevalence of chronic diseases has aided the growth of the stem cell treatment industry.
Increased investments in R&D and emphasis on personalized medicine
Increasing demand for biologics, technological advancement in stem cell therapeutics, and a growing emphasis on the development of personalized medicines are all factors driving growth. The growing emphasis on the treatment of neurological disorders contributes to market growth. Furthermore, the growing popularity of personalized medicines is fueling market growth. Researchers are developing new procurement methods that can be used to develop personalized medicines. Furthermore, companies are focusing on developing therapies to alleviate the various stressors associated with COVID-19, which is increasing demand.
Ethical concerns and high costs associated with the market
High costs associated with the stem cell market and the lack of a well-defined framework are expected to hamper the market growth. Also, because stem cells are derived by destroying the human embryo, they raise several ethical concerns. Human embryos are regarded as potential life, and destroying them is considered unethical. Concerns about the use of embryonic stem cells in the development of stem cell therapy are limiting the global market growth.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
The global Stem cell therapy market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The presence of key players engaged in developing stem cell therapies, advanced healthcare infrastructure, extensive R&D, supportive reforms from healthcare organizations, and strong reimbursement policies all contribute to the North American region's growth. Because of the increasing development of stem cell-based therapies, government initiatives for developing regenerative medicines, the establishment of several stem cell banks, and the expansion of clinical trials for regenerative medicines, the region is expected to grow.
Stem cell therapy Market Segments:
|
Report Attribute |
Details |
| The market size value in 2021 | USD 11.43 billion |
| The revenue forecast in 2031 | USD 27.94 billion |
| Growth Rate | CAGR of 13.4% from 2021 to 2031 |
| The base year for estimation | 2020 |
| Quantitative units | Revenue in USD million and CAGR from 2021 to 2031 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Type, Technology, Application, and Region |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Key companies profiled | Osiris, Lineage Cell Therapeutics, Inc., Takara Bio Inc., Thermo Fisher Scientific Inc., Astellas Pharma Inc., Athersys, Inc., Cytori Therapeutics Inc., Fate Therapeutics, ReNeuron Group plc. and Other Prominent Players |
The Stem cell therapy Market size was estimated at USD 11.43 billion in 2021 and expected to reach USD 27.94 billion by 2031
Key players: Osiris, Lineage Cell Therapeutics, Inc., Takara Bio Inc., Thermo Fisher Scientific Inc., Astellas Pharma Inc., Athersys, Inc., Cytori Therapeutics Inc., Fate Therapeutics, ReNeuron Group plc.and Other Prominent Players
What could be the factors driving the growth of Stem cell therapy Market
Drivers: Increasing use in oncology and regenerative medicine and Increased investments in R&D and emphasis on personalized medicine
Stem cells, which can proliferate and develop into almost any cell type in the body, are used in surgery and medicine. The stem cell is the source of all cells in the human body. It can replicate itself as well as heal and replace damaged tissues in the human body.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
